FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/06/088707 [Registered on: 12/06/2025] Trial Registered Prospectively
Last Modified On: 07/06/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A study to see the added effect of Trunapanchmuladighrita and Gokshurachurna in treating mootrashmari 
Scientific Title of Study   A Randomised Controlled Clinical Trial of Add on effect of Trunapanchmuladighrita with Gokshurachurna in the management of Mootrashmari 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Akshay Haribhau Devarkar  
Designation  PG scholar  
Affiliation  Tilak Ayurved Mahavidyalaya and Seth Tarachand Ramnath charitable Ayurvedic Hospital 
Address  Tilak Ayurveda Mahavidyalaya ,Department of Shalyatantra 2nd floor, 583/2,Rastapeth,Pune

Pune
MAHARASHTRA
411011
India 
Phone  8698072410  
Fax    
Email  devarkarakshay81@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Dhanraj Gaikwad  
Designation  Assistant Professor Department of Shalyatantra 
Affiliation  Tilak Ayurved Mahavidyalaya and Seth Tarachand Ramnath charitable Ayurvedic Hospital 
Address  Tilak Ayurveda Mahavidyalaya ,Department of Shalyatantra ,2nd floor ,583/2,Rastapeth,Pune

Pune
MAHARASHTRA
411011
India 
Phone  9422342048  
Fax    
Email  draj.gaikwad@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Akshay Haribhau Devarkar 
Designation  PG scholar 
Affiliation  Tilak Ayurved Mahavidyalaya and Seth Tarachand Ramnath charitable Ayurvedic Hospital 
Address  Tilak Ayurveda Mahavidyalaya ,Department of Shalyatantra 2nd floor 583/2,Rastapeth,Pune

Pune
MAHARASHTRA
411011
India 
Phone  8698072410  
Fax    
Email  devarkarakshay81@gmail.com  
 
Source of Monetary or Material Support  
Tilak Ayurved Mahavidyalaya and Seth Tarachand Ramnath Charitable Ayurvedic Hospital, Rastapeth , Pune 411011 
 
Primary Sponsor  
Name  Tilak Ayurved Mahavidyalaya, Pune 
Address  Rastapeth Peth , Pune ,411011 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Akshay Haribhau Devarkar   Tilak Ayurved Mahavidyalaya and Seth Tarachand Ramnath Charitable Ayurvedic Hospital   OPD no.7 Department of Shalyatantra,Rastapeth,pune
Pune
MAHARASHTRA 
8698072410

devarkarakshay81@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Tilak Ayurved Mahavidyalaya and Seth Tarachand Ramnath charitable Ayurvedic Hospital , institutional Ethics Committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N22||Calculus of urinary tract in diseases classified elsewhere. Ayurveda Condition: MUTRAVAHASROTOVIKARAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Gokshurachurna , Reference: Sushruta Samhita chikitsasthna7/20 , Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 28 Days, anupAna/sahapAna: Yes(details: Madhu), Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: Trunapanchmuladi ghrita, Reference: Chakradatta 39, Route: Oral, Dosage Form: Ghrita, Dose: 10(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 28 Days, anupAna/sahapAna: Yes(details: Koshnajala), Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details 
1. Size of calculus-A known diagnosed case of Non obstructive ureteric calculus 4 to 7 mm.

2. Age group -18 to 60 years with irrespective of gender 
 
ExclusionCriteria 
Details  1. Participants who are suffering from severe systemic disorders like renal failure, Carcinoma Known case of DM, HTN, Asthma, HIV, HbsAg

2.Congenital anomalies of kidney.

3.The pregnant women 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Efficacy of Trunapanchmuladi ghrita with Gokshura churna in managing Mootrashmari, assessed by reduction in symptom severity scores and overall treatment response.  1st follow up after 7 days and then 14 days and 28 days 
 
Secondary Outcome  
Outcome  TimePoints 
1. Reduction in Calculus Size and Expulsion:

Change in size of urinary calculi (measured via imaging techniques like ultrasound or CT).

Rate of spontaneous expulsion of calculi during or after treatment.



2. Symptom Improvement:

Reduction in individual symptoms such as:

Abdominal pain

Burning micturition

Hematuria


Measured using standardized symptom scoring or patient-reported outcomes.



3. Adverse Drug Reactions (ADR):
Incidence and severity of any adverse drug reactions observed during the treatment period. 
18 points 
 
Target Sample Size   Total Sample Size="64"
Sample Size from India="64" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   18/06/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  



Objective

To evaluate the efficacy of Trunapanchmuladi Ghrita combined with Gokshura Churna versus Gokshura Churna alone in treating Mootrashmari (urinary stones).


Study Design


Open, randomized controlled clinical trial


Duration 28 days


Sample size: 64 participants   32 per group



Participants:


Adults aged 18–60 with non-obstructive ureteric calculi (4–7 mm)


Exclusions include systemic illnesses, pregnancy, and congenital kidney anomalies



Interventions:


Group A: Trunapanchmuladi Ghrita + Gokshura Churna


Group B: Gokshura Churna alone


Both groups advised pathya-apathya and hydration



Assessment Parameters:


Subjective: Pain, burning micturition, hematuria


Objective: Size, site, and number of stones via USG


Statistical analysis: Wilcoxon Signed Rank Test, Unpaired t-test



Rationale:

Ayurveda offers promising and cost-effective alternatives to conventional treatments for kidney stones, which often recur after modern interventions.


Expected Outcome:

To determine whether the add-on therapy provides statistically and clinically significant improvement in symptom relief and stone reduction.

 
Close